Author Topic: (Abst.) Progressive multifocal leukoencephalopathy...  (Read 4 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9664
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Progressive multifocal leukoencephalopathy...
« on: July 25, 2023, 09:34:54 am »

When Tysabri was the newest MS drug, it wasn't long before we began hearing of cases of progressive multifocal leukoencephalopathy (PML). But we kept hearing that these were very very rare, and not to be too concerned. However, other MS drugs came along, and some of them led to some other cases of PML. And some people with PML died.

But not to worry. PML is so very rare. However, the medical profession is concerned about it, as is evident in this abstract.

From PubMed (July 25, 2023)--"Progressive multifocal leukoencephalopathy:  Pathogenesis, diagnostic tools, and potential biomarkers of response to therapy":

From the abstract:

In the last two decades, there has been increasing concern among patients and the medical community as PML was observed as an adverse event in individuals treated with modern (selective) immune suppressive treatments for various immune-mediated diseases, especially multiple sclerosis (MS). It became evident that this devastating complication also needs to be considered beyond the patient populations historically at risk, including those with hematological malignancies or HIV-infected individuals.
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.


Related Topics

  Subject / Started by Replies Last post
0 Replies
Last post October 20, 2016, 10:37:25 am
by agate
0 Replies
Last post November 02, 2017, 04:05:33 pm
by agate
0 Replies
Last post January 25, 2019, 02:31:15 pm
by agate
1 Replies
Last post December 06, 2021, 09:19:58 pm
by agate
0 Replies
Last post June 06, 2021, 05:17:56 pm
by agate